Simply Wall St.
Bullish biote Insiders Loaded Up On US$1.01m Of Stock
📊
AI Sentiment
Positive
7/10
- Home
- BTMD
BTMD
Biote Corp.
as of 02-09-2026 3:26pm EST
$2.19
$0.04
-2.02%
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | IRVING |
| Market Cap: | 80.4M | IPO Year: | N/A |
| Target Price: | $6.00 | AVG Volume (30 days): | 164.4K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.78 | EPS Growth: | 270.48 |
| 52 Week Low/High: | $2.03 - $5.03 | Next Earning Date: | 03-11-2026 |
| Revenue: | $195,645,000 | Revenue Growth: | 1.34% |
| Revenue Growth (this year): | -0.86% | Revenue Growth (next year): | 2.37% |
| P/E Ratio: | 2.88 | Index: | N/A |
| Free Cash Flow: | 34.4M | FCF Growth: | -2.40% |
AI-Powered BTMD Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 68.59%
68.59%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Biote Corp. News
BTMD Breaking Stock News: Dive into BTMD Ticker-Specific Updates for Smart Investing
Compare BTMD vs Leading Stocks
See how BTMD stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "BTMD Biote Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.